Three-year Experience of Antimicrobial Stewardship in a Tertiary Care Hospital in Pakistan: Successes and Challenges
DOI:
https://doi.org/10.69926/pklijhs.63Keywords:
Antimicrobial stewardship, compliance, antimicrobial resistance, cost savingsAbstract
Background: Antimicrobial resistance (AMR) is on the rise globally. One strategy proposed by WHO to curtail AMR includes establishing antimicrobial stewardship (AS) programs. The objective of this study was to describe the practices of antimicrobial use at the Indus Hospital and Health Network (IHHN) and share their experience of establishing an AS program.
Methods: The Infectious Diseases (ID) department at IHHN, Korangi Campus, established an AS program in 2020. In the first phase (2020-2022), pharmacist-led reviews were performed on selected cases of injudicious antimicrobial use. In 2023, a prospective audit and feedback methodology was adopted. Frequencies and percentages were reported for categorical variables. SPSS 19 was used for data analysis.
Results: A total of 789 cases were analyzed across both phases. Overall compliance with AS recommendations was approximately 80%. Seven out of nine departments showed improved adherence over time, with cardiology and nephrology achieving over 90% compliance. The majority of antimicrobials reviewed (79%) were categorized in the WHO Watch group. In 2023 alone, AS interventions led to a direct cost saving of PKR 2,441,682 (approximately USD 12,000) and prevented administration of at least 1,765 antimicrobial doses. De-escalation or discontinuation of empiric therapy after 72 hours was the most frequent recommendation. Notably, 40% of cases reviewed did not require any antibiotics.
Conclusion: Implementing AS programs is crucial for monitoring and optimizing antimicrobial use. The IHHN model demonstrates the effectiveness of interdisciplinary collaboration, pharmacist-led reviews, and continuous education to promote rational antimicrobial use in a resource-limited setting.
References
1. Fleming A. On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzæ. Br J Exp Pathol. 1929;10(3):226-36.
2. Abraham EP, Chain E. An enzyme from bacteria able to destroy penicillin. Nature. 1940;146(3713):837. doi:10.1038/146837a0.
3. Agnew E, Dolecek C, Hasan R, Lahra M, Merk H, Perovic O, et al. Global antimicrobial resistance and use surveillance system (GLASS) report 2021. Geneva: World Health Organization; 2021.
4. World Health Organization. Antimicrobial resistance: briefing to WHO Member States 2023 [Internet]. Geneva: World Health Organization; 2023 [cited 2025 Aug 20]. Available from: https://apps.who.int/gb/MSPI/pdf_files/2023/03/Item1_22-03.pdf
5. Qureshi S, Maria N, Zeeshan M, Irfan S, Qamar FN. Prevalence and risk factors associated with multi-drug resistant organisms (MDRO) carriage among pediatric patients at the time of admission in a tertiary care hospital of a developing country: a cross-sectional study. BMC Infect Dis. 2021;21(1):547. doi:10.1186/s12879-021-06275-5.
6. Jamil A, Bukhari NT, Lashari Y, Rajput U, Anis T, Muneer A, et al. Prevalence and control of multi drug resistant (MDR) nosocomial pathogens isolated from hospital wards (surgical, medical, paediatric and labor unit). Microbiol Res J Int. 2019;26(4):1-12. doi:10.9734/MRJI/2018/45312.
7. Adnan F, Khursheed N, Khan M, Ali MM, Hussain S, Mansoor N. Changing trends of multidrug resistant bacteria: a six-year experience from a tertiary care hospital. J Ayub Med Coll Abbottabad. 2022;34(3):442-6. doi:10.55519/JAMC-03-9395.
8. Hussain A, Satti L, Hanif F, Zehra NM, Nadeem S, Bangash TM, et al. Typhoidal Salmonella strains in Pakistan: an impending threat of extensively drug-resistant Salmonella Typhi. Eur J Clin Microbiol Infect Dis. 2019;38(11):2145-9. doi:10.1007/s10096-019-03658-0.
9. Khan MA, Bilal W, Asim H, Rahmat ZS, Essar MY, Ahmad S. MDR-TB in Pakistan: challenges, efforts, and recommendations. Ann Med Surg (Lond). 2022;79:104009. doi:10.1016/j.amsu.2022.104009.
10. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35(10 Suppl 2):S165-93. doi:10.1016/j.ajic.2007.10.006.
11. National Institute of Health Pakistan. Antimicrobial resistance 2024 [Internet]. Islamabad: National Institute of Health Pakistan; 2024 [cited 2025 Aug 20]. Available from: https://www.nih.org.pk/antimicrobial-resistance
12. Association for Professionals in Infection Control and Epidemiology. Antimicrobial stewardship 2024 [Internet]. Arlington (VA): APIC; 2024 [cited 2025 Aug 20]. Available from: https://apic.org/professional-practice/practice-resources/antimicrobial-stewardship/
13. Mudenda S, Daka V, Matafwali SK. World Health Organization AWaRe framework for antibiotic stewardship: where are we now and where do we need to go? An expert viewpoint. Antimicrob Steward Healthc Epidemiol. 2023;3(1):e84. doi:10.1017/ash.2023.164.
14. IBM Corp. IBM SPSS Statistics for Windows, version 19.0. Armonk (NY): IBM Corp; 2010.
15. Zheng N, Li J, Liu Y, Liao K, Chen J, Zhang C, et al. Evaluation of implementation and effectiveness of China's antibiotic stewardship in the First Affiliated Hospital of Sun Yat-sen University. Antibiotics (Basel). 2023;12(4):770. doi:10.3390/antibiotics12040770.
16. Kolar M, Htoutou Sedlakova M, Urbanek K, Mlynarcik P, Roderova M, Hricova K, et al. Implementation of antibiotic stewardship in a university hospital setting. Antibiotics (Basel). 2021;10(1):93. doi:10.3390/antibiotics10010093.
17. Swamy A, Sood R, Kapil A, Vikram NK, Ranjan P, Jadon RS, et al. Antibiotic stewardship initiative in a Medicine unit of a tertiary care teaching hospital in India: a pilot study. Indian J Med Res. 2019;150(2):175-85. doi:10.4103/ijmr.IJMR_951_17.
18. Pethani A, Riaz A, Perveen S, Saleem AF. Situational analysis of antimicrobial stewardship program (ASP) among public and private sector tertiary care hospitals in Karachi, Pakistan: a qualitative case study. Antimicrob Steward Healthc Epidemiol. 2023;3(1):e161. doi:10.1017/ash.2023.427.
19. Duane TM, Zuo JX, Wolfe LG, Bearman G, Edmond MB, Lee K, et al. Surgeons do not listen: evaluation of compliance with antimicrobial stewardship program recommendations. Am Surg. 2013;79(12):1269-72. doi:10.1177/000313481307901218.
20. Langford BJ, Nisenbaum R, Brown KA, Chan A, Downing M. Antibiotics: easier to start than to stop? Predictors of antimicrobial stewardship recommendation acceptance. Clin Microbiol Infect. 2020;26(12):1638-43. doi:10.1016/j.cmi.2020.07.048.
21. Bashar MA, Miot J, Shoul E, van Zyl RL. Impact of an antibiotic stewardship programme in a surgical setting. S Afr J Infect Dis. 2021;36(1):a307. doi:10.4102/sajid.v36i1.307.
22. Wee LE, Chung SJ, Tang SLS, Liew YX, Tan LY, Cherng PZB, et al. Who listens and who doesn't? Factors associated with adherence to antibiotic stewardship intervention in a Singaporean tertiary hospital. J Glob Antimicrob Resist. 2020;22:391-7. doi:10.1016/j.jgar.2020.04.006.
23. Hussain M. Antibiotic stewardship in Pakistan: a solution to antibiotic resistance. J Sheikh Zayed Med Coll. 2022;13(2):1-2.
24. Mahmoudi L, Sepasian A, Firouzabadi D, Akbari A. The impact of an antibiotic stewardship program on the consumption of specific antimicrobials and their cost burden: a hospital-wide intervention. Risk Manag Healthc Policy. 2020;13:1701-9. doi:10.2147/RMHP.S265407.
25. Sheikh S, Vishwas G, Aggarwal M, Bhattacharya S, Kumari P, Parashar L, et al. Antibiotic point prevalence survey at a tertiary healthcare hospital in India: identifying strategies to improve the antibiotic stewardship program immediately after a COVID-19 wave. Infect Prev Pract. 2022;4(4):100253. doi:10.1016/j.infpip.2022.100253.
26. Rashid MM, Akhtar Z, Chowdhury S, Islam MA, Parveen S, Ghosh PK, et al. Pattern of antibiotic use among hospitalized patients according to WHO Access, Watch, Reserve (AWaRe) classification: findings from a point prevalence survey in Bangladesh. Antibiotics (Basel). 2022;11(6):810. doi:10.3390/antibiotics11060810.
27. Cairns KA, Jenney AWJ, Abbott IJ, Skinner MJ, Doyle JS, Dooley M, et al. Prescribing trends before and after implementation of an antimicrobial stewardship program. Med J Aust. 2013;198(5):262-6. doi:10.5694/mja12.11683.
28. Altaf U, Saleem Z, Akhtar MF, Altowayan WM, Alqasoumi AA, Alshammari MS, et al. Using culture sensitivity reports to optimize antimicrobial therapy: findings and implications of antimicrobial stewardship activity in a hospital in Pakistan. Medicina (Kaunas). 2023;59(7):1237. doi:10.3390/medicina59071237.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Naseem Salahuddin, Quratulain Shaikh, Samreen Sarfaraz, Aneela Hussain, Aamir Sikander Kazi, Muhammad Hamid Hanif, Mujahid Hussain
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PKLI-JHS adopts the CC BY 4.0 license (Creative Commons Attribution 4.0 International License). For specifics, please refer to the full license legal code. The journal utilizes a non-exclusive licensing agreement for open access publishing, allowing authors to retain copyright and primary scholarly usage rights while granting the journal publication and distribution rights.
